Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus®

Clinical trial NCT01288170 · UNKNOWN

Trial details

NCT number: NCT01288170
Sponsor: Erempharma
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2010-02-01
Primary completion: 2010-07-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.